These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 33888147)

  • 1. MSC-derived exosomes carrying a cocktail of exogenous interfering RNAs an unprecedented therapy in era of COVID-19 outbreak.
    Jamalkhah M; Asaadi Y; Azangou-Khyavy M; Khanali J; Soleimani M; Kiani J; Arefian E
    J Transl Med; 2021 Apr; 19(1):164. PubMed ID: 33888147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem cells and their derived exosomes to combat Covid-19.
    Yousefi Dehbidi M; Goodarzi N; Azhdari MH; Doroudian M
    Rev Med Virol; 2022 Mar; 32(2):e2281. PubMed ID: 34363275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects.
    Abdelgawad M; Bakry NS; Farghali AA; Abdel-Latif A; Lotfy A
    Stem Cell Res Ther; 2021 Aug; 12(1):469. PubMed ID: 34419143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stalling SARS-CoV2 infection with stem cells: can regenerating perinatal tissue mesenchymal stem cells offer a multi-tiered therapeutic approach to COVID-19?
    Warrier S; Mohana Sundaram S; Varier L; Balasubramanian A
    Placenta; 2022 Jan; 117():161-168. PubMed ID: 34915433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes.
    Taghavi-Farahabadi M; Mahmoudi M; Soudi S; Hashemi SM
    Med Hypotheses; 2020 Nov; 144():109865. PubMed ID: 32562911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential roles of mesenchymal stem cells and their exosomes in the treatment of COVID-19.
    Cheng X; Jiang M; Long L; Meng J
    Front Biosci (Landmark Ed); 2021 Oct; 26(10):948-961. PubMed ID: 34719217
    [No Abstract]   [Full Text] [Related]  

  • 7. Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients.
    Al-Khawaga S; Abdelalim EM
    Stem Cell Res Ther; 2020 Oct; 11(1):437. PubMed ID: 33059757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential therapeutic application of mesenchymal stem cell-derived exosomes in SARS-CoV-2 pneumonia.
    Akbari A; Rezaie J
    Stem Cell Res Ther; 2020 Aug; 11(1):356. PubMed ID: 32795359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment.
    Jayaramayya K; Mahalaxmi I; Subramaniam MD; Raj N; Dayem AA; Lim KM; Kim SJ; An JY; Lee Y; Choi Y; Raj A; Cho SG; Vellingiri B
    BMB Rep; 2020 Aug; 53(8):400-412. PubMed ID: 32731913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cell (MSC)-derived exosomes as a cell-free therapy for patients Infected with COVID-19: Real opportunities and range of promises.
    Rezakhani L; Kelishadrokhi AF; Soleimanizadeh A; Rahmati S
    Chem Phys Lipids; 2021 Jan; 234():105009. PubMed ID: 33189639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proposed Mechanisms of Targeting COVID-19 by Delivering Mesenchymal Stem Cells and Their Exosomes to Damaged Organs.
    Jamshidi E; Babajani A; Soltani P; Niknejad H
    Stem Cell Rev Rep; 2021 Feb; 17(1):176-192. PubMed ID: 33432484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cell alongside exosomes as a novel cell-based therapy for COVID-19: A review study.
    Dauletova M; Hafsan H; Mahhengam N; Zekiy AO; Ahmadi M; Siahmansouri H
    Clin Immunol; 2021 May; 226():108712. PubMed ID: 33684527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal Stem Cell-Derived Exosomes Exhibit Promising Potential for Treating SARS-CoV-2-Infected Patients.
    Raghav A; Khan ZA; Upadhayay VK; Tripathi P; Gautam KA; Mishra BK; Ahmad J; Jeong GB
    Cells; 2021 Mar; 10(3):. PubMed ID: 33799966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diverse Effects of Exosomes on COVID-19: A Perspective of Progress From Transmission to Therapeutic Developments.
    Gurunathan S; Kang MH; Kim JH
    Front Immunol; 2021; 12():716407. PubMed ID: 34394121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomes contribution in COVID-19 patients' treatment.
    Mazini L; Rochette L; Malka G
    J Transl Med; 2021 May; 19(1):234. PubMed ID: 34059065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal Stem Cell Derived Exosomes: a Nano Platform for Therapeutics and Drug Delivery in Combating COVID-19.
    Pinky ; Gupta S; Krishnakumar V; Sharma Y; Dinda AK; Mohanty S
    Stem Cell Rev Rep; 2021 Feb; 17(1):33-43. PubMed ID: 32661867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nebulization Therapy with Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes for COVID-19 Pneumonia.
    Chu M; Wang H; Bian L; Huang J; Wu D; Zhang R; Fei F; Chen Y; Xia J
    Stem Cell Rev Rep; 2022 Aug; 18(6):2152-2163. PubMed ID: 35665467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Could Mesenchymal Stem Cell-Derived Exosomes Be a Therapeutic Option for Critically Ill COVID-19 Patients?
    Gardin C; Ferroni L; Chachques JC; Zavan B
    J Clin Med; 2020 Aug; 9(9):. PubMed ID: 32858940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MSC-NTF (NurOwn®) exosomes: a novel therapeutic modality in the mouse LPS-induced ARDS model.
    Kaspi H; Semo J; Abramov N; Dekel C; Lindborg S; Kern R; Lebovits C; Aricha R
    Stem Cell Res Ther; 2021 Jan; 12(1):72. PubMed ID: 33468250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cell treatment for COVID-19.
    Xu R; Feng Z; Wang FS
    EBioMedicine; 2022 Mar; 77():103920. PubMed ID: 35279630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.